GC
ASND icon

Gilbert & Cook’s Ascendis Pharma A/S ASND Stock Holding History

Gilbert & Cook’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Sell
8,543
-39
-0.5% -$9.11K 0.26% 30
2026
Q1 		$1.96M Sell
8,582
-55
-0.6% -$12.3K 0.25% 32
2025
Q4 		$1.84M Buy
8,637
+1,835
+27% +$379K 0.23% 36
2025
Q3 		$1.35M Buy
6,802
+52
+0.8% +$9.7K 0.17% 57
2025
Q2 		$1.17M Buy
6,750
+131
+2% +$21.3K 0.16% 61
2025
Q1 		$1.03M Buy
6,619
+2,198
+50% +$314K 0.15% 64
2024
Q4 		$609K Buy
4,421
+1,858
+72% +$244K 0.09% 114
2024
Q3 		$383K Sell
2,563
-56
-2% -$7.56K 0.05% 158
2024
Q2 		$357K Sell
2,619
-262
-9% -$35.6K 0.05% 159
2024
Q1 		$436K Buy
2,881
+43
+2% +$6.14K 0.06% 158
2023
Q4 		$357K Buy
2,838
+220
+8% +$21.9K 0.05% 175
2023
Q3 		$245K Buy
+2,618
New +$245K 0.04% 192

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Gilbert & Cook's ASND Position: Q2 2026 in Review

Gilbert & Cook reduced its Ascendis Pharma A/S (ASND) stake by 0.45% in Q2 2026, selling an estimated $9.11K and leaving 8,543 shares worth $2.28M. The position accounts for 0.26% of the portfolio, ranked #30.

Gilbert & Cook first reported a position in ASND in Q3 2023 and has held it in 12 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Gilbert & Cook held 8,543 shares of Ascendis Pharma A/S worth $2.28M as of Q2 2026.
  • Gilbert & Cook sold 39 Ascendis Pharma A/S shares in Q2 2026, an estimated $9.11K.
  • Ascendis Pharma A/S made up 0.26% of Gilbert & Cook's portfolio in Q2 2026, its #30 holding.
  • Gilbert & Cook first reported a position in Ascendis Pharma A/S in Q3 2023 and has held it in 12 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Gilbert & Cook's 13F filing for Q2 2026, filed 28 Jul 2026.